相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma
Atul Bhatnagar et al.
JOURNAL OF MASS SPECTROMETRY (2020)
Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and Δ(4)-abiraterone from cancer patients
Atul Bhatnagar et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
LC-MS/MS assay for the quantification of testosterone, dihydrotestosterone, androstenedione, cortisol and prednisone in plasma from castrated prostate cancer patients treated with abiraterone acetate or enzalutamide
Merel van Nuland et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Pharmacokinetics and bioequivalence of generic and branded abiraterone acetate tablet: a single-dose, open-label, and replicate designed study in healthy Chinese male volunteers
Chunhua Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives
Patrick Caron et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry
Atul Bhatnagar et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects
Cuiyun Li et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
An LC-MS/MS method for quantification of the active abiraterone metabolite Δ(4)-abiraterone (D4A) in human plasma
Merel van Nuland et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS
Kyu-pyo Kim et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Development and validation of a novel LC-MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column
Mohammad Alyamani et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Development and Validation of an LC-MS/MS Method for the Simultaneous Quantification of Abiraterone, Enzalutamide, and Their Major Metabolites in Human Plasma
Merel van Nuland et al.
THERAPEUTIC DRUG MONITORING (2017)
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma
Guillemette E. Benoist et al.
BIOMEDICAL CHROMATOGRAPHY (2017)
A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer
Rana R. McKay et al.
CLINICAL CANCER RESEARCH (2016)
Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy
Zhenfei Li et al.
NATURE (2016)
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
Kristine M. Wadosky et al.
ONCOTARGET (2016)
New drugs in prostate cancer
Sangjun Yoo et al.
PROSTATE INTERNATIONAL (2016)
Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy
Benjamin A. Gartrell et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Development and validation of a highly sensitive method for the determination of abiraterone in rat and human plasma by LC-MS/MS-ESI: application to a pharmacokinetic study
Sandip Gurav et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
A validated liquid chromatographic-tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma
Vanessa Martins et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Androgen deprivation therapy for prostate cancer
N Sharifi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
分享论文
